Skin signs of gastrointestinal disease

Gastroenterology

Volumn 124, Issue 6, 2003, Pages 1595-1614

  Braverman, Irwin M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ACRODERMATITIS ENTEROPATHICA; CROHN DISEASE; DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL POLYPOSIS; HUMAN; INTESTINE BYPASS; MALABSORPTION; MALIGNANT ATROPHIC PAPULOSIS; MASTOCYTOSIS; PANCREATITIS; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SKIN MANIFESTATION; ULCERATIVE COLITIS;

EID: 0037518117     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00327-5     Document Type: Review

References (125)

1. Aassar OS, Friedman CM, White RI Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 1991;101:977.
2. Porteous MEM, Burn J, Proctor SJ. Hereditary hemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992;29:527.
3. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology 1986;91:1079.
4. White RI Jr, Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long term outcome of embolotherapy. Radiology 1988;169:663.
5. Guttmacher AE, Marchuk DA, White RI Jr. Current concepts. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918.
6. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986;110:331.
7. Bernard G, Mion F, Henry L, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology 1993;105:482.
8. Conlon CL, Weinger RS, Cimio PL, et al. Telangiectasia and von Willebrand's disease in two families. Ann Intern Med 1978;89:921.
9. McAlister KA, Grogg KM, Johnson PW, et al. Endoglin, a TGF-binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet 1994;8:345.
10. Neldner KH. Pseudoxanthoma elasticum. Clin Dermatol 1988;6:1.
11. Weary PE, Linthicum A, Cawley EP, et al. Gardner's syndrome. Arch Dermatol 1964;90:20.
12. Holländer E. Carcinom und hautveränderungen. Zentralbl Chir 1902;29:457.
13. Oldfield MC. Association of familial polyposis of colon with multiple sebaceous cysts. Br J Surg 1954;41:534.
14. Traboulsi EI, Maumenee IH, Krush AJ, et al. Congenital hypertrophy of the retinal pigment epithelium predicts colorectal polyposis in Gardner's syndrome. Arch Ophthalmol 1990;108:525.
15. Shields JA, Shields CL, Shah PG, et al. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner's syndrome. Ophthalmology 1992;99:1709.
16. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994;331:1694.
17. Dormandy TL. Gastrointestinal polyposis with mucocutaneous pigmentation (Peutz-Jeghers syndrome). N Engl J Med 1957;256:1093.
18. Zegarelli EV, Kutschef AH, Mercadante JM, et al. Atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome). Am J Dig Dis 1959;4:479.
19. Lowe NJ. Peutz-Jeghers syndrome with pigmented oral papillomas. Arch Dermatol 1975;111:503.
20. Valero A, Sherf K. Pigmented nails in Peutz-Jeghers syndrome. Am J Gastroenterol 1965;43:56.
21. Reid JD. Duodenal cancer in the Peutz-Jeghers syndrome. Cancer 1965;18:970.
22. Veraalsi S, Cavicchini S, Benelli C, Gasparini G. Laugier-Hunziker syndrome: a clinical, histopathologic, and ultrastructural study of four cases and review of the literature. J Am Acad Dermatol 1991;25:632.
23. Dozois RR, Judd ES, Dahlin DC, Bartholomew LG. The Peutz Jeghers syndrome. Is there a predisposition to the development of intestinal cancer? Arch Surg 1969;98:509.
24. Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1512.
25. Cronkhite LW Jr, Canada WJ. Generalized gastrointestinal polyposis. An unusual syndrome of polyposis pigmentation, alopecia and onychotrophia. N Engl J Med 1955;252:1011.
26. Johnson MM, Vosburgh JW, Wiens AT, Walsh GC. Gastrointestinal polyposis associated with alopecia, pigmentation and atrophy of the fingernails and toenails. Ann Intern Med 1962;56:935.
27. Goto A, Mimoto H, Shibuya C, Matsunami E. Cronkhite-Canada syndrome: an analysis of clinical features and follow-up studies of 80 cases reported in Japan. Arch Jpn Chir 1988;57:506.
28. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991;90:606.
29. Lynch HT, Lynch PM, Pester J, Fusaro RM. The Cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med 1981;141:607.
30. Stevens MB, Hookman P, Siegal CI, et al. Aperistalsis of the esophagus in patients with connective tissue disorders and Raynaud's phenomenon. N Engl J Med 1964;270:1218.
31. Braverman IM. Skin signs of systemic disease. 3rd ed. Philadelphia: Saunders, 1998;384.
32. Chisholm M, Wright R. Post-cricoid dysphagia and iron deficiency in men. BMJ 1967;2:281.
33. Schetman D. The Plummer-Vinson syndrome. Arch Dermatol 1972;105:720.
34. Katz J, Gryboski JD, Rosenbaum HM, Spiro HM. Dysphagia in children with epidermolysis bullosa. Gastroenterology 1967;52:259.
35. Reed WB, College J Jr, Francis MJ, et al. Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol 1974;110:894.
36. Parker RI. Hematologic aspects of mastocytosis: management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 1991;96:525.
37. Parker RI. Hematologic disorders of mastocytosis: management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 1991;96:52S.
38. Brown J, Winkelmann RK, Randall RV. Acanthosis nigricans and pituitary tumors. JAMA 1966;198:619.
39. McKissic ED. Malignant acanthosis nigricans and anesthesia. Anesthesiology 1975;42:357.
40. Curth HO. Dermatoses and malignant tumors. Arch Dermatol 1955;71:95.
41. Utsinger PD, Shapiro RF, Ely PH, et al. Clinical and immunologic study of the postintestinal bypass arthritis-dermatitis syndrome. Arthritis Rheum 1978;21:599.
42. Strole WE Jr, Clark WH Jr, Isselbacher KJ. Progressive arterial occlusive disease (Köhlmeier-Degos). N Engl J Med 1967;276:195.
43. Roenigk HH Jr, Farmer RG. Degos' disease (malignant papulosis). JAMA 1968;206:1508.
44. May RE. Degos' syndrome. BMJ 1968;1:161.
45. Howard RO, Klaus SN, Savin RC, Fenton R. Malignant atrophic papulosis (Degos' syndrome). Arch Ophthalmol 1968;79:262.
46. Köhlmeier W. Multiple Hautnekrosen bei Thrombangiitis Obliterans. Arch Dermatol Syph 1941;181:783.
47. Degos R, Delort J, Tricot R. Dermatite papulo-squameuse atrophiante. Bull Soc Fr Dermatol Syph 1942;48:148.
48. Snow JL, Muller SA. Degos syndrome: malignant atrophic papulosis. Semin Dermatol 1995;14:99.
49. Stahl D, Thomsen K, Hou-Jensen K. Malignant atrophic papulosis. Treatment with aspirin and dipyridamole. Arch Dermatol 1978;114:1687.
50. Drucker CR. Malignant atrophic papulosis: response to antiplatelet therapy. Dermatologica 1990;180:90.
51. Englert HJ, Hawkes CH, Boey ML, et al. Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant. BMJ 1984;8:289.
52. Assier H, Chosidow O, Piette JC, et al. Absence of antiphospholipid and anti-endothelial cell antibodies in malignant atrophic papulosis. A study of 15 cases. J Am Acad Dermatol 1995;33:831.
53. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227.
54. Azizi E, Fisher BK. Cutaneous manifestations of familial Mediterranean fever. Arch Dermatol 1976;112:364.
55. Heite H-J, Ody R. Die Acrodermatitis enteropathica im Lichte der Haufigkeitsanalyse. Hautarzt 1965;16:529.
56. Olholm-Larsen P. Untreated acrodermatitis enteropathica in adults. Dermatologica 1978;156:155.
57. Kelly R, Davidson GP, Townley RR, Campbell PE. Reversible intestinal mucosal abnormality in acrodermatitis enteropathica. Arch Dis Child 1976;51:219.
58. van Vloten WA, Bos LP. Skin lesions in acquired zinc deficiency due to parenteral nutrition. Dermatologica 1978;156:175.
59. Weismann K, Wadskov S, Mikkelsen HI, et al. Acquired zinc deficiency dermatosis in man. Arch Dermatot 1978;114:1509.
60. Brazin SA, Johnson WT, Abramson LJ. The acrodermatitis enteropathica-like syndrome. Arch Dermatol 1979;115:597.
61. Quirk CM, Seykora J, Wingate BJ, Cotserelis G. Acrodermatitis enteropathica associated with anorexia nervosa. JAMA 2002;288:2655.
62. McClain C, Soutor C, Zieve L. Zinc deficiency: a complication of Crohn's disease. Gastroenterology 1980;78:272.
63. Samitz MH, Greenberg MS. Skin lesions in association with ulcerative colitis. Gastroenterology 1951;19:476.
64. Johnson ML, Wilson HTH. Skin lesions in ulcerative colitis. Gut 1969;10:255.
65. Piette F, Colombel JF, Delaporte E. Manifestations dermatologiques des maladies inflammatoires du tube digestif. Ann Dermatol Venerol 1992;119:29.
66. Fernandez-Herlihy L. The articular manifestations of chronic ulcerative colitis. An analysis of 555 cases. N Engl J Med 1959;261:259.
67. Moschella SL. Pyoderma gangrenosum. Arch Dermatol 1967;95:121.
68. Perry HO, Brunsting LA. Pyoderma gangrenosum. Arch Dermatol 1957;75:380.
69. Schwaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT. Pyoderma gangrenosum: a review. J Am Acad Dermatol 1988;18:559.
70. Ricketts WE, Kirsner JB, Rothman S. Pyoderma gangrenosum in chronic non-specific ulcerative colitis. Am J Med 1948;5:69.
71. O'Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978;114:1061.
72. McCarthy P, Shklar G. A syndrome of pyostomatitis vegetans and ulcerative colitis. Arch Dermatol 1963;88:913.
73. Dantzig PI. Pyoderma gangrenosum. N Engl J Med 1975;292:47.
74. Wernig RH, Davis MDP, Dahl PR, Su WPD. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002;347:1412.
75. Graef V, Baggenstoss AH, Sauer WG, Spittell JA Jr. Venous thrombosis occurring in nonspecific ulcerative colitis. Arch Intern Med 1966;117:377.
76. Lee JC, Spittell J-A Jr, Sauer WG, et al. Hyper-coagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology 1968;54:76.
77. Bargen JA, Barker NW. Extensive arterial and venous thromboses complicating chronic ulcerative colitis. Arch Intern Med 1936;58:17.
78. Kehoe EL, Newcomer KL. Thromboembolic phenomena in ulcerative colitis. Arch Intern Med 1964;113:711.
79. McCallum DI, Kinmont PDC. Dermatological manifestations of Crohn's disease. Br J Dermatol 1968;80:1.
80. Baker WNW, Milton-Thompson GJ. Management of anal fistulae in Crohn's disease. Proc R Soc Med 1974;67:58.
81. Baker WNW, Milton-Thompson GJ. The anal lesion as the sole presenting symptom of intestinal Crohn's disease. Gut 1971;12:865.
82. McCallum DI. Personal communication. 1975.
83. Gasser P, Affolter H, Schuppisser JP, Herzog U. Akrale vasospasmen bei M. crohn. Schweiz Med Wochenschr 1992;122:693.
84. Verbov JL. The skin in patients with Crohn's disease and ulcerative colitis. Trans St Johns Hosp Dermatol Soc 1973;59:30.
85. Schulman D, Beck LS, Roberts IM, Schwartz AM. Crohn's disease of the vulva. Am J Gastroenterol 1987;82:1328.
86. Verbov JL. Crohn's disease with mouth and lip involvement. Br J Dermatol 1973;88:517.
87. Noble J-P, Vaillant J-M, Auriol M, Hewitt J. Localization bucale de la maladie de Crohn. Ann Dermatol Venereol 1983;110:747.
88. Cooke WT, Peeney ALP, Hawkins CF. Symptoms, signs and diagnostic features of idiopathic steatorrhea. QJM 1953;22:59.
89. Green PA, Wollaeger EE. The clinical behavior of sprue in the United States. Gastroenterology 1960;38:399.
90. Wells GC. Skin disorders in relation to malabsorption. BMJ 1962;2:937.
91. Dent CE, Garretts M. Skin changes in hypocalcemia. Lancet 1960;1:142.
92. Friedman M, Hare PJ. Gluten sensitive enteropathy and eczema. Lancet 1965;1:521.
93. Shuster S, Marks J. Dermatogenic enteropathy. Lancet 1965;1:1367.
94. Brice SL, Jester JD, Huff JC. Recurrent aphthous stomatitis. Curr Probl Dermatol 1991;3:107.
95. Zaenglein AL, Hafer L, Helm KF. Diagnosis of dermatitis herpetiformis by an avidin-biotin-peroxidase method. Arch Dermatol 1995;131:571.
96. Fry K, Keir P, McMinn RMH, et al. Small bowel structure and function and hematologic changes in dermatitis herpetiformis. Lancet 1967;2:729.
97. Brow JR, Parker F, Weinstein MW, Rubin CE. The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesions and associated malabsorption. Gastroenterology 1971;60:355.
98. Weinstein WM, Brow JR, Parker F, Rubin CE. The small intestinal mucosa in dermatitis herpetiforms. II. Relationship of the small intestinal lesion to gluten. Gastroenterology 1971;60:362.
99. Shuster S, Watson AJ, Marks J. Coeliac syndrome in dermatitis herpetiformis. Lancet 1968;1:1101.
100. Bendl BJ, Williams PB. Histopathological changes in the jejunal mucosa in dermatitis herpetiformis. CMAJ 1968;98:575.
101. Katz SI, Strober W. The pathogenesis of dermatitis herpetiformis. J Invest Dermatol 1978;70:63.
102. Fry L, Seah PP, Riches DJ, Hoffbrand AV. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1973;1:288.
103. Marks R, Whittle MW. Results of treatment of dermatitis herpetiformis with a gluten-free diet after one year. BMJ 1969;4:772.
104. Hall RP, Lawley TJ, Heck JA, Katz SI. IgA-containing immune complexes in dermatitis herpetiformis. Henoch-Schonlein purpura, systemic lupus erythematosus and other diseases. Clin Exp Immunol 1980;40:431.
105. Lawley TJ, Hall RP, Fauci AS, et al. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype. Studies in patients with dermatitis herpetiformis and normal subjects. N Engl J Med 1981;304:185.
106. Fry L, Shuster S, McMinn RMH. D-xylose absorption in patients with eczema. BMJ 1965;1:967.
107. Doran CK, Everett MA, Welsh JD. The D-xylose tolerance test. Arch Dermatol 1966;94:574.
108. Knowles JP, Shuster S, Wells GC. Folic acid deficiency in patients with skin disease. Lancet 1963;1:1138.
109. Burns WA, Matthews MJ, Hamosh M, et al. Lipase-secreting acinar cell carcinoma of the pancreas with polyarthropathy. A light and electron microscopic, histochemical, and biochemical study. Cancer 1974;33:1002.
110. Szymanski FJ, Bluefarb SM. Nodular fat necrosis and pancreatic diseases. Arch Dermatol 1961;83:224.
111. Wuketich S, Pavlik F. Syndrome of metastasizing lipase forming pancreatic adenoma: differential diagnosis of Pfeifer-Weber-Christian disease. Arch Klin Exp Dermatol 1963;216:412.
112. Hashizume T, Kiryu H, Noda K, et al. Glucagonoma syndrome. J Am Acad Dermatol 1988;19:377.
113. Stacpoole PW. The glucagonoma syndrome: clinical features, diagnosis, and treatment. Endocrinol Rev 1981;2:347.
114. Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St Johns Hosp Dermatol Soc 1973;59:244.
115. Binnick AN, Spencer SK, Dennison WL Jr, Horton ES. Glucagonoma syndrome. Report of two cases and literature review. Arch Dermatol 1977;113:749.
116. Gonzalez JR, Botet MV, Sanchez JL. The histopathology of acrodermatitis enteropathica. Am J Dermatopathol 1982;4:303.
117. Boden G, Owen E. Familial hyperglucagonemia - an autosomal dominant disorder. N Engl J Med 1977;296:534.
118. Sweet RD. A dermatosis specifically associated with a tumor of pancreatic alpha cells. Br J Dermatol 1974;90:301.
119. Warin AP. Necrolytic migratory erythema with carcinoma of pancreas. Proc R Soc Med 1974;67:2.
120. Peterson LL, Shaw JC, Acott KM, et al. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid. J Am Acad Dermatol 1984;11:468.
121. Soter NA, Lewis RA, Corey EJ, Austen KF. Local effects of synthetic leukotrienes (LTC4, LTD4, and LTB4) in human skin. J Invest Dermatol 1983;80:115.
122. Goodenberger DM, Lawley TJ, Strober W, et al. Necrolytic migratory erythema without glucagonoma. Report of two cases. Arch Dermatol 1979;115:1429.
123. Thivolet J. Necrolytic migratory erythema without glucagonoma. Arch Dermatol 1981;117:4.
124. Doyle JA, Schroeter AL, Rogers RS III. Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis: possible pseudoglucagonoma syndrome. Br J Dermatol 1979;100:581.
125. Franchimont C, Pierard G, Luyckx AS. Angioplastic necrolytic migratory erythema: unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide. Am J Dermatopathol 1982;4:485.